Attached files

file filename
10-Q - FORM 10-Q - Precipio, Inc.d10q.htm
EX-31.2 - CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - Precipio, Inc.dex312.htm
EX-31.1 - CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - Precipio, Inc.dex311.htm
EX-10.1 - LICENSE AGREEMENT BETWEEN THE COMPANY AND THE DANA-FARBER CANCER INSTITUTE - Precipio, Inc.dex101.htm
EX-10.2 - LICENSE AGREEMENT BETWEEN THE COMPANY AND POWER3 MEDICAL PRODUCTS, INC. - Precipio, Inc.dex102.htm
EX-32.1 - CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - Precipio, Inc.dex321.htm

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended September 30, 2009, I, Debra A. Schneider, Chief Financial Officer of Transgenomic, Inc., hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

 

(1) Such Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended September 30, 2009, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in such Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended September 30, 2009, fairly presents, in all material respects, the financial condition and results of operations of Transgenomic, Inc.

 

/s/ DEBRA A. SCHNEIDER

 

Debra A. Schneider

Chief Financial Officer

Date: November 5, 2009

A signed original of the certification required by Section 906 has been provided to Transgenomic, Inc. and will be retained by Transgenomic, Inc and furnished to the Securities and Exchange Commission or its staff upon request.